Clinical trial
A Prospective Randomized Placebo Controlled Study to Evaluate the Effect of Celecoxib on the Efficacy and Safety of Amlodipine on Renal and Vascular Function in Subjects With Existing Hypertension Requiring Antihypertensive Therapy
NCT02979197 is registered in ClinicalTrials.gov with Kitov Pharma Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Randomized Placebo Controlled Study to Evaluate the Effect of Celecoxib on the Efficacy and Safety of Amlodipine on Renal and Vascular Function in Subjects With Existing Hypertension Requiring Antihypertensive Therapy
- Lead sponsor
- Kitov Pharma Ltd
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- November 3, 2016
- Completion date
- July 21, 2017
- Enrollment
- 105 (actual)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.